Caris Life Sciences (CAI) Interest Coverage Ratio (2024 - 2026)
Caris Life Sciences (CAI) recorded quarterly Interest Coverage Ratio of 0.41 in Q1 2026, down 94.7% quarter-over-quarter from 7.79 in Q4 2025, and up 109.1% on a YoY basis from 0.2 in Q1 2025.
Caris Life Sciences (CAI) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Caris Life Sciences' Interest Coverage Ratio history runs 3 years deep, the most recent figure standing at 0.41 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 109.1% year-over-year to 0.41; the TTM figure through Mar 2026 stood at 1.9 (up 145.74% YoY), while the FY2025 annual figure was 0.79, up 115.44% from the prior year.
- Interest Coverage Ratio was 0.41 for Q1 2026 at Caris Life Sciences, down from 7.79 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 7.79 in Q4 2025 to a low of 4.9 in Q2 2024.
- Historically, Interest Coverage Ratio has averaged 0.87 across 3 years, with a median of 1.86 in 2025.
- Biggest YoY gain for Interest Coverage Ratio was 378.71% in 2025; the steepest drop was 80.89% in 2025.
- A 3-year view of Interest Coverage Ratio shows it stood at 2.79 in 2024, then jumped by 378.71% to 7.79 in 2025, then slumped by 94.7% to 0.41 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.41 (Q1 2026), 7.79 (Q4 2025), and 2.42 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Caris Life Sciences | 5.22 Bn | 4.40 Bn | 171.13 Mn | 0.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.41 |
| Dec 31, 2025 | 7.79 |
| Sep 30, 2025 | 2.42 |
| Jun 30, 2025 | -0.94 |
| Mar 31, 2025 | -4.53 |
| Dec 31, 2024 | -2.79 |
| Sep 30, 2024 | -4.41 |
| Jun 30, 2024 | -4.90 |